The use of teplizumab (Tzield) in the treatment of type 1 diabetes (T1D) has shown promising results, according to the PROTECT trial. This randomized study demonstrated that early administration of teplizumab can help preserve beta-cell function and delay disease progression in individuals with T1D. Although the drug did not improve glucose control or reduce hypoglycemia
Health
The arrival of long-acting injectable antiretroviral therapy (ART) has brought a new option for providers and patients with HIV. This innovative treatment offers an alternative to daily oral pills, which can be burdensome for some individuals. Long-acting ART provides convenience, reduces pill burdens, and may help prevent stigmatization. However, while this treatment option has shown
Blood transfusions are a common and critical intervention in the treatment of critically ill patients. However, determining the appropriate amount of blood to transfuse is often a complex decision with significant implications for patient outcomes. In a recent single-center study, Janet Adegboye, MD, of Johns Hopkins University, explored the relationship between hemoglobin levels and in-hospital
A groundbreaking revelation in the field of multiple sclerosis (MS) research suggests that a cure for this debilitating disease may be within reach. Renowned MS researcher, Stephen Hauser, MD, of the University of California San Francisco, discussed the potential for advancing from suppressing the disease to finding a cure during his keynote speech at the
Penicillin is one of the most common allergies reported by patients in their electronic health records (EHRs). However, recent research suggests that a significant portion of these patients may not truly be allergic to penicillin. In a quality-improvement project conducted at a community hospital, Dr. Ibrahim Shah and his colleagues aimed to explore methods of
Breast cancer is a significant health concern globally, and accurate prognosis estimation is crucial for effective treatment decisions. The PREDICT prognostication tool has been developed to estimate survival rates in breast cancer patients. A recent study conducted by researchers at Case Western Reserve University School of Medicine in Cleveland evaluated the accuracy of the PREDICT
The world of social media has become a platform for healthcare professionals to showcase their expertise and inspire others. While the number of Hispanic physicians is relatively low, a group of TikTok creators have gained popularity and created a space for themselves in the medfluencer world. In this article, we will explore the profiles of
In a recent randomized controlled trial conducted in Vietnam and Indonesia, researchers found that the addition of dexamethasone to the treatment regimen for tuberculous (TB) meningitis in heavily immunosuppressed HIV-positive patients did not significantly improve survival or provide any other measurable benefits. The study, published in the New England Journal of Medicine, examined 520 HIV-positive
At the recent Psych Congress 2023, the renowned psychiatrist Dr. Peter Weiden presented a thought-provoking session titled “State of the Science: Focus on Schizophrenia.” As a clinical professor of psychiatry at the Renaissance School of Medicine at Stony Brook University in New York, Weiden delved into the latest research findings and emerging treatments in schizophrenia.
Obesity-related heart failure with preserved ejection fraction (HFpEF) has quickly gained recognition as a prevalent, debilitating, and deadly condition. The current treatments for heart failure, such as beta-blockers and renin-angiotensin system inhibitors, have limited efficacy in patients with obesity-related HFpEF. However, a prespecified secondary analysis of the STEP-HFpEF trial has demonstrated the potential of semaglutide